0RGI vs ALKS: Side-by-Side Comparison
Compare COSMO Pharmaceuticals SA (0RGI) and Alkermes plc (ALKS) side by side: P/E 50.2 vs 60.7. Financials, growth and model signals on Bullrun.
| Metric | 0RGI | ALKS |
|---|---|---|
| Company | COSMO Pharmaceuticals SA | Alkermes plc |
| Country / Exchange | Ireland · LSE | Ireland · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers-Specialty & Generic |
| Market cap | — | USD 9.10B |
| P/E ratio | 50.2 | 60.7 |
| Dividend yield | — | — |
| Valuation model | — | 51.7% overvalued |
| Revenue (FY2025) | GBP 104.17M | USD 1.48B |
| Revenue growth YoY | -61.0% | -5.2% |
| Net income | GBP -3.61M | USD 241.70M |
| Gross margin | 48.5% | 86.7% |
| Diluted EPS | — | 1.43 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.